This is the issue. At least 20% of total patients receive Qbrexza.
This is Botanix's research!
If they also said during the briefing Botox is 100,000 patients, well how can that be??
Their briefing/research makes no sense when assessed against the fact that is Qbrexza's $25m of annual revenue.
Anyway, my last post as Im sure nobody appreciates the downramp and as I intend to hold for a long time to go it's certainly not in my interest to keep banging on about it. Mostly I'm just pissed that they won't even acknowledge my enquires on the matter.
Ann: Trading Halt, page-112
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.020(5.26%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $1.832M | 5.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 1023317 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 3589 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |